Skip to main content
OpenTrials
Completed

NCT Number: NCT02606188

Modified HFNC Oxygen in Patients Undergoing Bronchoscopy.

The purpose of this study is to determine whether the Modified High-flow nasal cannula is effective in the oxygen of the patients undergoing bronchoscopy.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Bronchoscopy,Oxygen

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Department of respiratory and critical care medicine,Beijing Chaoyang Hospital

Beijing, Beijing Municipality, 100020, China

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age more than 18 years old;
  • need for bronchoscopy for diagnosis purpose.

Exclusion criteria

  • peripheral arterial pulse oximetry was < 90%
  • platelet count < 60 × 109/L;
  • nasopharyngeal obstruction or blockage.

Treatment and study plan

Modified High-flow nasal cannula

Device

Modified High-flow nasal cannula

Nasal Cannula

Device

Conventional oxygen therap

Primary outcomes

  1. the proportion of patients SpO2 < 90% during bronchoscopy

    Time frame: 1 hour

Secondary outcomes

  1. the operation time

    Time frame: 1 hour

Sponsors and collaborators

Lead sponsor

Haichao Li

Other

Registry information

Official study title

Modified High-flow Nasal Cannula Oxygen in Patients Undergoing Bronchoscopy.

Important dates

Study start
2015
Primary completion
2019
Study completion
2019
First posted
Nov 17, 2015
Registry last updated
Aug 19, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.